Research ArticleCancer

Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening

See allHide authors and affiliations

Science Translational Medicine  20 Nov 2019:
Vol. 11, Issue 519, eaaw0064
DOI: 10.1126/scitranslmed.aaw0064

Article Information

vol. 11 no. 519

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication November 9, 2018
  • Resubmitted July 22, 2019
  • Accepted for publication October 31, 2019
  • .

Author Information

  1. Grant L. Lin1,
  2. Kelli M. Wilson2,
  3. Michele Ceribelli2,
  4. Benjamin Z. Stanton3,
  5. Pamelyn J. Woo1,
  6. Sara Kreimer1,
  7. Elizabeth Y. Qin1,
  8. Xiaohu Zhang2,
  9. James Lennon1,
  10. Surya Nagaraja1,
  11. Patrick J. Morris2,
  12. Michael Quezada1,
  13. Shawn M. Gillespie1,
  14. Damien Y. Duveau2,
  15. Aleksandra M. Michalowski4,
  16. Paul Shinn2,
  17. Rajarshi Guha2,
  18. Marc Ferrer2,
  19. Carleen Klumpp-Thomas2,
  20. Sam Michael2,
  21. Crystal McKnight2,
  22. Paras Minhas1,
  23. Zina Itkin2,
  24. Eric H. Raabe5,
  25. Lu Chen2,
  26. Reem Ghanem1,
  27. Anna C. Geraghty1,
  28. Lijun Ni1,
  29. Katrin I. Andreasson1,
  30. Nicholas A. Vitanza1,
  31. Katherine E. Warren6,*,,
  32. Craig J. Thomas2,7, and
  33. Michelle Monje1,8,9,10,11,12,
  1. 1Department of Neurology, Stanford University School of Medicine, Stanford, CA 94305, USA.
  2. 2Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA.
  3. 3Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children’s Hospital, The Ohio State University College of Medicine, Columbus, OH 43205, USA.
  4. 4Laboratory of Cancer Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  5. 5Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  6. 6Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  7. 7Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  8. 8Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
  9. 9Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA.
  10. 10Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
  11. 11Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
  12. 12Stanford Institute for Stem Cell and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  1. Corresponding author. Email: katherinee_warren{at}dfci.harvard.edu (K.E.W.); craigt{at}mail.nih.gov (C.J.T.); mmonje{at}stanford.edu (M.M.)
  • * Present address: Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children’s Hospital, Boston, MA 02115, USA.

Altmetric

Article usage

Article usage: November 2019 to May 2020

AbstractFullPdf
Nov 201961841220637
Dec 20191879442303
Jan 20201069214181
Feb 2020960174125
Mar 2020537110115
Apr 20202808064
May 20205268067

Stay Connected to Science Translational Medicine